Provexis plc (PXS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.307x

Based on the latest financial reports, Provexis plc (PXS) has a cash flow conversion efficiency ratio of -0.307x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-187.53K ≈ $-22.82 USD) by net assets (GBX610.89K ≈ $74.33 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Provexis plc (PXS) total market value for the company's overall valuation and market capitalisation.

Provexis plc - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Provexis plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Provexis plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Provexis plc ranked by their cash flow conversion efficiency. Explore PXS cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
GCL Global Holdings Ltd Warrants NASDAQ:GCLWW	-0.003x
Checkit PLC LSE:CKT	-0.132x
Kavango Resources PLC LSE:KAV	-0.160x
GETT Gold Inc V:GETT	-0.004x
SkinBioTherapeutics PLC LSE:SBTX	-0.053x
International Zeolite Corp V:IZ	-0.053x
Hemogenyx Pharmaceuticals PLC LSE:HEMO	3.264x
SysGroup PLC LSE:SYS	0.029x

Annual Cash Flow Conversion Efficiency for Provexis plc (2004–2025)

The table below shows the annual cash flow conversion efficiency of Provexis plc from 2004 to 2025. View Provexis plc (PXS) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX763.82K ≈ $92.93	GBX-340.83K ≈ $-41.47	-0.446x	+55.59%
2024-03-31	GBX190.59K ≈ $23.19	GBX-191.50K ≈ $-23.30	-1.005x	-27.11%
2023-03-31	GBX657.65K ≈ $80.02	GBX-519.85K ≈ $-63.25	-0.790x	-258.73%
2022-03-31	GBX969.08K ≈ $117.91	GBX-213.54K ≈ $-25.98	-0.220x	+3.97%
2021-03-31	GBX1.14 Million ≈ $138.97	GBX-262.07K ≈ $-31.89	-0.229x	+78.15%
2020-03-31	GBX318.68K ≈ $38.77	GBX-334.64K ≈ $-40.72	-1.050x	+7.33%
2019-03-31	GBX338.89K ≈ $41.23	GBX-384.01K ≈ $-46.72	-1.133x	-2.77%
2018-03-31	GBX329.26K ≈ $40.06	GBX-363.05K ≈ $-44.17	-1.103x	+93.62%
2017-03-31	GBX24.89K ≈ $3.03	GBX-430.30K ≈ $-52.36	-17.291x	-574.63%
2016-03-31	GBX142.84K ≈ $17.38	GBX-366.10K ≈ $-44.54	-2.563x	-55.70%
2015-03-31	GBX245.90K ≈ $29.92	GBX-404.78K ≈ $-49.25	-1.646x	-53.62%
2014-03-31	GBX535.08K ≈ $65.10	GBX-573.34K ≈ $-69.76	-1.072x	-491.02%
2013-03-31	GBX7.91 Million ≈ $961.92	GBX-1.43 Million ≈ $-174.40	-0.181x	+5.42%
2012-03-31	GBX11.30 Million ≈ $1.37K	GBX-2.17 Million ≈ $-263.54	-0.192x	-7.20%
2011-03-31	GBX11.48 Million ≈ $1.40K	GBX-2.05 Million ≈ $-249.79	-0.179x	-31.87%
2010-03-31	GBX11.06 Million ≈ $1.35K	GBX-1.50 Million ≈ $-182.51	-0.136x	+44.43%
2009-03-31	GBX5.53 Million ≈ $673.08	GBX-1.35 Million ≈ $-164.26	-0.244x	-24.48%
2008-03-31	GBX7.58 Million ≈ $922.88	GBX-1.49 Million ≈ $-180.92	-0.196x	+40.54%
2007-03-31	GBX6.61 Million ≈ $804.12	GBX-2.18 Million ≈ $-265.12	-0.330x	-6.14%
2006-03-31	GBX8.85 Million ≈ $1.08K	GBX-2.75 Million ≈ $-334.47	-0.311x	+87.48%
2005-03-31	GBX510.00K ≈ $62.05	GBX-1.26 Million ≈ $-153.91	-2.480x	+64.89%
2004-03-31	GBX108.00K ≈ $13.14	GBX-763.00K ≈ $-92.84	-7.065x	--

About Provexis plc

LSE:PXS UK Drug Manufacturers - Specialty & Generic

Market Cap

$308.26K

GBX2.53 Billion GBX

Market Cap Rank

#31229 Global

#990 in UK

Share Price

GBX1.08

Change (1 day)

+0.47%

52-Week Range

GBX0.56 - GBX1.51

All Time High

GBX1.51